Your browser doesn't support javascript.
loading
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.
Shen, Yingying; Liu, Qi; Li, Hangchao; Liu, Wenbin; Hu, Huijin; Zhao, Yuechao; Li, Yuzhu; Chen, Ying; Liu, Shan; Yu, Qinghong; Zhuang, Haifeng; Wu, Liqiang; Hu, Zhiping; Zheng, Zhiyin; Shen, Jianping; Lin, Shenyun; Shen, Yiping; Zhou, Yuhong; Ye, Baodong; Wu, Dijiong.
Afiliación
  • Shen Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Liu Q; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Li H; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Liu W; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Hu H; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Zhao Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Li Y; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Chen Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Liu S; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Yu Q; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Zhuang H; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Wu L; The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Hu Z; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Zheng Z; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Shen J; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Lin S; Department of Clinical Evaluation Center, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
  • Shen Y; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Zhou Y; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
  • Ye B; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, #54 Youdian Road, Hangzhou, 310006, Zhejiang, China.
  • Wu D; National TCM Clinical Research Base (Hematology), Hangzhou, Zhejiang, China.
Ann Hematol ; 102(3): 503-517, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36622392
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pancitopenia / Proteínas del Grupo de Complementación de la Anemia de Fanconi / Anemia Aplásica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pancitopenia / Proteínas del Grupo de Complementación de la Anemia de Fanconi / Anemia Aplásica Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China